19 results
8-K
EX-1.1
oqj ohkjwykc912n
30 Jan 20
Catabasis Pharmaceuticals Announces Pricing of $23 Million Underwritten Public Offering
4:03pm
8-K
EX-1.1
cwmtcglg8l6m52i5f
6 Feb 19
Catabasis Pharmaceuticals Announces Pricing of $20 Million Underwritten Public Offering
4:13pm
424B3
tnyuz e6o89uau
13 Nov 18
Prospectus supplement
8:52am
8-K
EX-1.1
37yfs5 uogtnud
13 Nov 18
Entry into a Material Definitive Agreement
8:48am
8-K
EX-1.1
54vx9k2
20 Jun 18
Catabasis Pharmaceuticals Announces Pricing of $42 Million Underwritten Public Offering
9:13am
8-K
EX-1.1
m6pzyx4teoo1l
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
10-K
qttd 7xmt
15 Mar 16
Annual report
12:00am
DRS/A
yb012aoqks73ws1x04t8
5 Mar 15
Draft registration statement (amended)
12:00am
DRS
wnuyule2q ou
23 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next